Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions.
<h4>Background</h4>Leprosy, a chronic granulomatous disease affecting the skin and nerves, is caused by Mycobacterium leprae (M. leprae). The type of leprosy developed depends upon the host immune response. Type 1 reactions (T1Rs), that complicate borderline and lepromatous leprosy, are...
Saved in:
| Main Authors: | Anna L Cogen, Stephen L Walker, Chrissy H Roberts, Deanna A Hagge, Kapil D Neupane, Saraswoti Khadge, Diana N J Lockwood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001869&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous Leishmaniasis: Revisited
by: Saraswoti Neupane
Published: (2018-03-01) -
Cutaneous Leishmaniasis: Revisited
by: Saraswoti Neupane
Published: (2018-03-01) -
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.
by: Becky L Rivoire, et al.
Published: (2014-01-01) -
Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.
by: Marian C Aldhous, et al.
Published: (2009-07-01) -
A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.
by: Saba M Lambert, et al.
Published: (2016-04-01)